Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/BGT stock hub

ASX/BGT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/BGTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.4M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/BGT

In the news

Latest news · ASX/BGT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-202.2

P25 -118.7P50 -49.4P75 -1.2

ROIC-127.2

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/BGT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

AUD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 9.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000BGT8
Last refreshed	2026-05-10
Market cap	AUD 10.4M
Price	AUD 0.03
Price currency	AUD
Sector	Healthcare
Sic	2870
Symbol	asx/BGT
Website	https://www.bio-gene.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.3%
EV Earnings	-3.69x
P/B ratio	8.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	AUD 80,346
Net Income	AUD -2.5M
Net Income Growth Quarters	6%
Net Income Growth Years	0%
ROA	-94.9
Roa5y	-39.71
ROCE	-217
ROE	-202.2
Roe5y	-72.91
ROIC	-127.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.34%
Cagr3y	-36.04%
Cagr5y	-27.94%
EPS Growth Quarters	6
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	AUD 1.5M
Cash	AUD 1.1M
Current Assets	AUD 1.3M
Current Liabilities	AUD 305,321
Equity	AUD 1.2M
Liabilities	AUD 307,709
Long Term Assets	AUD 158,442
Long Term Liabilities	AUD 2,388
Net Cash	AUD 1.1M
Net Cash By Market Cap	AUD 10.42
Net Cash Growth	-19.21%
Net Debt Equity	AUD -0.93
Tangible Book Value	AUD 1M
Tangible Book Value Per Share	AUD 0
WACC	8.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.31
Net Working Capital	AUD -70,248
Quick ratio	3.64
Working Capital	AUD 1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.33%
200-day SMA	0.03
3Y total return	-73.85%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.57%
All Time High	0.35
All Time High Change	-90.29%
All Time High Date	2022-03-02
All Time Low	0.02
All Time Low Change	112.5%
All Time Low Date	2025-06-24
ATR	0
Beta	0.78
Beta1y	0
Beta2y	-0.55
Ch YTD	47.83
High	0.04
High52	0.06
High52 Date	2025-09-23
High52ch	-44.26%
Low	0.03
Low52	0.02
Low52 Date	2025-07-02
Low52ch	112.5%
Ma50ch	-2.3%
Price vs 200-day SMA	24.09%
RSI	43.45
RSI Monthly	44.91
RSI Weekly	53.8
Sharpe ratio	0.52x
Sortino ratio	1.01
Total Return	-34.05%
Tr YTD	47.83
Tr1m	6.25%
Tr1w	-8.11%
Tr3m	3.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -2.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	127,735,869%
Shares Insiders	39.31%
Shares Out	305,061,108
Shares Qo Q	37.27%
Shares Yo Y	34.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	110,724.5x
Bv Per Share	0
Ch1m	6.25
Ch1w	-8.11
Ch1y	13.33
Ch3m	3.03
Ch3y	-73.85
Ch5y	-80.57
Ch6m	30.77
Change	-2.86%
Change From Open	-2.86
Close	0.04
Days Gap	0
Depreciation Amortization	44,556
Dollar Volume	3,228.2
Earnings Date	2026-05-11
EBIT	AUD -2.5M
EBITDA	AUD -2.5M
EPS	AUD -0.01
F Score	1
Financing CF	2,360,795
Fiscal Year End	June
Founded	1,995
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-12-31
Ma150	0.03
Ma150ch	14.48%
Ma20	0.04
Ma20ch	-5.82%
Net CF	-257,055
Next Earnings Date	2026-05-11
Open	0.04
Position In Range	50
Ppne	10,671
Price Date	2026-05-08
Ptbv Ratio	10.18
Relative Volume	0.89x
Tr6m	30.77%
Volume	94,946

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/BGT pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/BGT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/BGT?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+39.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+34.1%

Negative means the company is buying back shares.

Technical

ASX/BGT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.5

Neutral momentum band

Price vs 200-day MA

+24.1%

50/200-day relationship not available

Beta (5Y)

0.78

Less volatile than the market

Sharpe ratio

0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/BGT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/BGT stock rating?

asx/BGT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/BGT analysis?

The full report lives at /stocks/asx/BGT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/BGT?

The latest report frames asx/BGT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/BGT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.